Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women

Infectious Agents and Cancer

Volumn 6, Issue 1, 2011, Pages

  Vidal, Adriana C ^a   Murphy, Susan K ^a   Hernandez, Brenda Y ^b   Vasquez, Brandi ^a   Bartlett, John A ^a   Oneko, Olola ^c   Mlay, Pendo ^c   Obure, Joseph ^c   Overcash, Francine ^a   Smith, Jennifer S ^d   Van Der Kolk, Mike ^e   Hoyo, Cathrine ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^d IL   (United States)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cervical intraepithelial neoplasia (CIN); Human papillomavirus (HPV); invasive cervical cancer (ICC)

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOLOGY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 82; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; TANZANIA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

EID: 81055149885     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-6-20     Document Type: Article

References (39)

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer 2008 127 2893 2917
2. The causal relationship between human papillomavirus and cervical cancer. Bosch FX, Lorincz A, Munoz N, Meijer CJL, Shah KV, J Clin Pathol 2002 55 244 265 10.1136/jcp.55.4.244 11919208 (Pubitemid 34293391)
3. Strategies Against Human Papillomavirus Infection and Cervical Cancer. Jung WW, Chun T, Sul D, Hwang KW, Kang HS, Lee DJ, Han IK, J Microbiol 2004 42 255 266 15650698 (Pubitemid 40137889)
4. Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer. Tjalma WAA, Arbyn M, Paavonen J, Van Waes TR, Bogers JJ, Int J Gynecol Cancer 2004 14 751 761 10.1111/j.1048-891X.2004.014505.x 15361181 (Pubitemid 39238157)
5. The epidemiology of human papillomavirus infections. Review. Baseman JG, Koutsky LA, J Clin Virol 2005 32 Suppl 16 S24 15753008
6. Human papilomavirus is a necessary cause of invasive cervical cancer worldwide. JM M, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snidjers PJ, Peto J, Meijer CJL, Munoz N, J Pathol 1999 189 12 19 10.1002/(SICI)1096- 9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482 (Pubitemid 29406813)
7. HPV genotypes in CIN 2-3 lesions and cervical cancer: a population-based study. Sigurdsson K, Taddeo FJ, Benediktsdottir KR, Olafsdottir K, Sigvaldason H, Oddsson K, Rafnar T, Int J Cancer 2007 121 2682 2687 10.1002/ijc.23034 17724723 (Pubitemid 350136412)
8. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Coutlee F, Ratnam S, Ramanakumar AV, Insinga RP, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL, J Med Virol 2011 83 1034 1041 10.1002/jmv.22081 21503917
9. Comparison of HPV type distribution in high-grade cervical lesions and cervical intraepithelial neoplasia grade 3. Clifford GM, Smith JS, Aguado T, Franceschi S, Cancer Epidemiol Biomarkers Prev 2003 19 1675 1681
10. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the Unites States. Insinga RP, Liaw KL, Johnson LG, Madeleine MM, Cancer Epidemiol Biomarkers Prev 2008 17 1611 11622 10.1158/1055-9965.EPI-07-2922 18628412
11. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Munoz N, Bosch FX, Castellsague X, Diaz M, de-SanJose S, Hammouda D, Shah KV, Meijer CJL, Int J Cancer 2004 111 278 285 10.1002/ijc.20244 15197783 (Pubitemid 38924707)
12. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S, Br J Cancer 2003 88 63 73 10.1038/sj.bjc.6600688 12556961 (Pubitemid 36241220)
13. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJLM, Vaccine 2008 265 29 K41
14. Human papillomavirus genotypes in rural Mozambique. Castellsague X, Menendez C, Loscertales MP, Kornegay JR, dos Santos F, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P, Lancet 2001 358 1429 1430 10.1016/S0140-6736(01)06523-0 11705494 (Pubitemid 33055750)
15. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, Vansteelandt S, Quint W, Kleter B, Van Marck E, Temmerman M, Sex Transm Dis 2003 30 137 142 10.1097/00007435-200302000-00009 12567172 (Pubitemid 36184362)
16. Cervical human papilloma virus infection and squamous intraepithelial lesions in rural Gambia, West-Africa: viral sequence analysis and epidemiology. Wall SR, Scherf CF, Morrison L, Hart KW, West B, Ekpo G, Fiander AN, Man S, Gelder CM, G. Walraven G, Borysiewicz LK, Br J Cancer 2005 93 1068 1076 10.1038/sj.bjc.6602736 16106268 (Pubitemid 41548404)
17. Genital human papillomavirus genotypes in Northwestern Tanzania. Mayaud P, Weiss HA, Lacey CJN, Gill DK, Mabey DCW, J Clin Microbiol 2003 41 4451 4453 10.1128/JCM.41.9.4451-4453.2003 12958291 (Pubitemid 37099729)
18. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-I infection in Burkina Faso. Didelot-Rousseau MN, Nagot N, Costes-Martineau V, Valles X, Ouedraogo A, Konate I, Weiss HA, Van de Perre P, Mayaud P, Segondy M, Br J Cancer 2006 95 355 362 10.1038/sj.bjc.6603252 16832413 (Pubitemid 44187597)
19. The 2001 Bethesda system terminology. Apgar BS, Zoschnick L, Wright TC, Am Fam Physician 1998 68 10
20. Human papillomavirus genotype prevalence in high-grade squamous intraepithelial lesions and colposcopically normal women from Zimbabwe. Gravitt PE, Kamath AM, Gaffikin L, Chirenje ZM, Womack S, Shah KV, Int J Cancer 2002 100 729 732 10.1002/ijc.10538 12209615 (Pubitemid 34832987)
21. Validation, performance under field conditions, and cost-effectiveness of Capiullus HIV-1/HIV-2 and Determine HIV1/2 rapid human immunodeficiency virus antibody assays using sequencial and parallel testing algorithms in Tanzania. Mayhood MK, Afwamba IA, Odhiambo CO, Ndanu E, Thielman NM, Morrissey AB, Shao JF, Wells Pence B, Crump JA, J Clin Microbiol 2008 46 3946 3951 10.1128/JCM.01045-08 18923015
22. WHO International agency for research on cancer monograph working group: a review of human carcinogenesis-Part B: biological agents. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, Lancet Oncol 2009 10 321 322 10.1016/S1470-2045(09)70096-8 19350698
23. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM, Int J Cancer 2007 121 621 632 10.1002/ijc.22527 17405118 (Pubitemid 46986496)
24. Human papillomavirus (HPV) infection, HIV-1 infection and cervical cancer in Tanzania, East Africa. Ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Minha M, Kashaija P, Yu X, Meinhardt G, Gissman L, Pawlita M, Int J Cancer 1992 51 515 521 10.1002/ijc.2910510403 1318265
25. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. Chabaud M, Le Cann P, Mayelo V, Leboulleux D, Diallo AS, Enogat N, Afoutou JM, Anthonioz P, Coll-Seck AM, Coursaget P, J Med Virol 1996 49 259 263 10.1002/(SICI)1096-9071(199608)49:4<259::AID-JMV1>3.0.CO;2-2 8877756 (Pubitemid 26301096)
26. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Toure-Coulibaly K, Welffens-Ekre C, Dabis F, Orth G, Int J Cancer 1998 76 480 486 10.1002/(SICI)1097- 0215(19980518)76:4<480::AID-IJC6>3.0.CO;2-N 9590121 (Pubitemid 28227988)
27. Risk factors of invasive cervical cancer in Mali. Bayo S, Bosch FX, de Sanjose S, Munoz N, Combita AL, Coursaget P, Diaz M, Dolo A, van den Brule AJ, Meijer CJL, Int J Epidemiol 2002 31 202 209 10.1093/ije/31.1.202 11914322 (Pubitemid 34284928)
28. High prevalence of HPV16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. Kay P, Soeters R, Nevin J, Denny L, Dehaeck CMC, Williamson AL, J Med Virol 2003 71 265 273 10.1002/jmv.10479 12938202 (Pubitemid 37048470)
29. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Koushik A, Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, Coutlee F, Franco EL, Cancer Detect Prev 2005 29 307 316 10.1016/j.cdp.2005.06.007 16122882 (Pubitemid 41267288)
30. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE, Cancer Epidemiol Biomarkers Prev 2010 19 1675 1681 10.1158/1055-9965.EPI-10-0251 20615885
31. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. de San Jose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX, Lancet Infect Dis 2007 7 453 459 10.1016/S1473-3099(07)70158-5 17597569 (Pubitemid 46962343)
32. Human papillomavirus genotype prevalence in high-grade squamous intraepithelial lesions and colposcopically normal women from Zimbabwe. Gravitt PE, Kamath AM, Gaffikin L, Chirenje ZM, Womack S, Shah KV, Int J Cancer 2002 100 729 732 10.1002/ijc.10538 12209615 (Pubitemid 34832987)
33. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia? Adam E, Kaufman RH, Berkova Z, Icenogle J, Reeves WC, Am J Obstet Gynecol 1998 178 1235 1244 10.1016/S0002-9378(98)70328-X 9662307 (Pubitemid 28304626)
34. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Ho GYF, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL, Int J Cancer 1998 78 281 285 10.1002/(SICI)1097- 0215(19981029)78:3<281::AID-IJC3>3.0.CO;2-R 9766558 (Pubitemid 28445361)
35. Risk factors for cervical intraepithelial neoplasm in Alaska Native women: a pilot study. McLehose RF, Harpster A, Lanier AP, Schiff MA, Koehler K, Murphy N, Becker TM, Alaska Med 1999 41 76 85 10710795
36. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. Liaw KL, Hidelsheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, Scott DR, Scherman ME, Kurman RJ, Glass AG, Anderson SM, Schiffman MA, J Infect Dis 2001 183 8 15 10.1086/317638 11087198 (Pubitemid 32043036)
37. Human papillomavirus and cervical cancer- burden and assessment of causality. Bosch XF, de Sanjose S, J Natl Cancer Inst Monogr 2003 31 3 13 12807939
38. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. Bontkes HJ, deGruijl TD, Walboomers JM, Schiller JT, Dillner J, Helmerhorst TJ, Vereheijen RH, Schper RJ, Meijer CJL, J Gen Virol 1999 80 409 417 10073701 (Pubitemid 29095201)
39. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Louie KS, de Sanjose S, Mayaud P, Tropical Medicine and International Health 2009 14 1287 1302 10.1111/j.1365-3156.2009.02372.x 19772550